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        Langerhans cells (LCs) are a long-lived subset 
of tissue DCs that reside in the epidermis (  1  ). 
LCs acquire skin antigens, and then migrate to 
skin-draining LNs in both infl  ammatory and 
steady-state conditions (  2, 3  ). LCs are derived 
from colony-stimulating factor-1 (CSF1)  –  de-
pendent precursors that originate in the BM and 
migrate to the dermis before becoming fully dif-
ferentiated and populating the epidermis (  4, 5  ). 
LC development is aff  ected by TGF     1. BM cells 
cultured in granulocyte/macrophage CSF and 
TGF     1 generate LC-like cells, and LCs are absent 
from TGF     1       /       mice (  6  –  8  ). 
  In vivo, TGF     1 is secreted by leukocytes 
and nonhematopoietic cells, including keratino-
cytes, and has a pleiotropic role in the immune 
system (  9  ). There are three isoforms of TGF     , 
but TGF     1 is the dominant isoform within the 
immune system. TGF     1 binds to the TGF      
receptor II (TGF     RII) and ALK5 to activate 
Smad 2, 3, and 4. 
  Although it is clear that LC development 
requires TGF     1, the identity of the cell types 
responsible for secreting TGF     1, and whether 
TGF     1 acts directly on LCs or via an inter-
mediary cell type, is unresolved. In BM chime-
ric experiments, TGF     1   /       severe combined 
immunodefi  cient BM cells transferred into ir-
radiated TGF     1       /       severe combined immuno-
defi  cient mice are able to produce LCs (  10  ). 
Thus, TGF     1 derived from nonhematopoietic 
cells in the skin, such as keratinocytes, is not re-
quired, and secretion by a cell of hematopoietic 
origin is suffi   cient for LC development. How-
ever, BM cells from TGF     1       /       mice were also 
able to generate donor-derived LCs when in-
troduced into irradiated WT recipients, suggest-
ing that nonhematopoietic sources of TGF     1 
are suffi   cient to promote LC development (  11  ). 
Interestingly, intradermal, but not intravenous, 
introduction of TGF     1 into TGF     1       /       mice 
led to LC development, which suggests that 
TGF     1 acts on LC precursors within the skin ( 10  ). 
Thus, neither hematopoietic nor skin-derived 
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Cre transgene appears to be limited to epidermal LCs and 
to LCs that have migrated to the skin-draining LN, which 
is consistent with our prior experience using this BAC (  12  ). 
It is important to note that endogenous mouse Langerin is 
expressed by several populations of CD8           DCs that are pre-
sent throughout the secondary lymphoid tissue. We and others 
have shown that these cells are not derived from the epidermis 
(  12, 18, 19  ). These Langerin     , CD8      DCs were present in 
Langerin-Cre mice in many tissues (  Fig. 2 B  ). Although we 
are not sure why expression of Cre under the control of the 
human Langerin BAC locus is limited to epidermal LCs and 
not other mouse Langerin-expressing cells, it is clear that these 
other Langerin-positive cells do not express the transgene and 
will not confound the analysis of subsequent experiments. 
TGF     1 was required for LC development in these models, 
which leaves the source of TGF     1 that drives LC develop-
ment unresolved. 
  To more defi  nitively defi  ne the mechanisms by which 
TGF      promotes LC development in vivo, we developed 
two lines of mice that have a LC-specifi  c deletion of either 
the gene for TGF     1 or TGF     RII, thereby generating mice 
with LC precursors that cannot secrete or respond to the 
cytokine, respectively. 
    RESULTS AND DISCUSSION   
  Generation and validation of Langerin-Cre mice 
  To generate a mouse with selective expression of Cre recom-
binase in LCs, we used a genomic bacterial artifi  cial chromo-
some (BAC) transgenic system similar to one we recently 
developed to express diphtheria toxin in LCs ( 12  ). The human 
genomic BAC RP11-504o1 contains the gene for Langerin, 
which is expressed by fully developed LCs (  13, 14  ). Trans-
genic mice made with this BAC express Langerin specifi  cally 
in epidermal LCs (  12  ). The gene for a mammalian codon-
optimized version of Cre was inserted into the BAC DNA 
just after the start ATG codon in exon I of Langerin using 
homologous recombination (Fig. S1 A, available at http://
www.jem.org/cgi/content/full/jem.20071401/DC1) (  15, 16  ). 
The correct insertion of Cre into exon I was confi  rmed 
by PCR (not depicted) and by restriction digest (Fig. S2). 
A 72-kb NotI fragment of this modifi  ed BAC was used to 
generate a single Langerin-Cre transgenic founder from 20 
live births. Langerin-Cre mice are indistinguishable from lit-
termate controls and have normal numbers of LCs, dermal 
DCs, other DC subtypes, and B and T cells in their spleen 
and LN (unpublished data). 
  To validate that Cre expression was restricted to LCs, 
Langerin-Cre mice were bred to Rosa26-enhanced GFP (EGFP) 
mice that have EGFP inserted into a ubiquitously expressed 
genomic locus behind fl  oxed   “  stop  ”   sequences (  17  ). Cre ac-
tivity deletes the stop sequences, thereby allowing EGFP 
expression only in those cells that express the Cre transgene. 
To quantify the number of LCs expressing the Cre transgene, we 
examined epidermal single-cell suspensions by fl  ow cytometry. 
As expected, all epidermal MHC-II     , CD11c      LCs from 
Langerin-Cre      Rosa26-EGFP  f/f   mice showed expression of 
EGFP (  Fig. 1 A  , left, thick line). In contrast, EGFP was ex-
pressed only in a small subset of MHC-II      cells in dermal 
single-cell suspensions (  Fig. 1 A  , right).   These EGFP      cells 
are likely either LC precursors that reside in the dermis or 
epidermal LCs in the process of migrating though the dermis 
to regional LNs. EGFP      cells were not observed in littermate 
control mice. 
  EGFP could also be identifi  ed on CD11c  int   cells within the 
cutaneous LNs (  Fig. 1 B  ). These cells were CD8             and DEC-
205  bright  , which is consistent with their identity as LCs that 
have migrated to the skin-draining LN (  Fig. 1 C  ). Importantly, 
we did not observe EGFP expression in any other cell present 
in the LN. There were no detectable EGFP      cells in spleen, 
mesenteric LN, and thymus (  Fig. 2 A  ).   Thus, expression of the 
  Figure 1.     Langerin-Cre transgene is expressed by all epidermal 
LCs. (A) Langerin-Cre mice were bred onto the Rosa26.EGFP Cre reporter 
line. FACS analysis of epidermal and dermal single-cell suspensions gated 
on live MHC-II      cells  (Tg    , thick line; Tg        , thin line with shading). (B) Anal-
ysis of live gated cutaneous LN cells from Tg      (left) and Tg         (right)  mice 
showing a population of CD11c  int   GFP     cells in transgenic mice. (C) GFP    -
gated cells from Cre      mice are stained for DEC-205 (left, open) and CD8 
(right, open), compared with an isotype control (fi   lled).   JEM VOL. 204, October 29, 2007  2547
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from 0.02 to 0.59% of total epidermal cells compared with 
0.46  –  0.80% in littermate controls. Plotting the ratio of epi-
dermal LCs from Langerin-Cre      versus age-matched litter-
mate controls as a function of the age of the mouse revealed 
that as the mice aged, escaped LCs accumulated, and their 
percentage in the epidermis increased (  Fig. 3 B  ; P       0.05). 
To further investigate this fi  nding, we examined epidermal 
sheets by immunofl  uorescence for the presence of LCs. In 
young, 22-d-old mice, MHC-II      LCs were rare, and they 
appeared as individual cells (  Fig. 3 C  ). In mice at 60 d of age, 
single cells could no longer be identifi  ed. Instead, there were 
clusters of LCs scattered throughout the epidermis that, by 
day 89, were signifi  cantly larger. To confi  rm that these cells 
were, in fact, LCs, and not another cell type that colonized 
the epidermal niche in the absence of LCs, epidermal sheets were 
stained with both anti  –  MHC-II and anti-Langerin (Fig. S2). 
All of the MHC-II      cells in both young and old mice also 
expressed Langerin, thereby demonstrating that they are LCs. 
The fact that escaped LCs in Langerin-Cre TGF     RII  f/f   mice 
are found as single cells in young mice, but appear in increas-
ingly large clusters in older mice, supports the notion that 
fully diff  erentiated LCs derive from locally proliferating pre-
cursors in the steady state (  4, 21, 22  ). 
  LCs require autocrine/paracrine TGF    1 for development 
  There are many potential sources of TGF     1 available to the 
developing LC in the skin, including keratinocytes, fi  bro-
blasts, resident T cells, and LCs themselves (  9, 23  ). To exam-
ine whether autocrine secretion of TGF     1 participates in LC 
development, we bred Langerin-Cre mice to mice in which 
  LCs require the direct action of TGF     
  It is well established that TGF     1 is required for LC develop-
ment (  6  –  8  ). Given that nearly all cells express receptors for 
TGF     1, it is less clear whether LCs have a direct requirement 
for TGF     1 or if TGF     1 acts via another cell type, which then 
assists with LC development. To examine this, Langerin-Cre 
mice were bred to mice carrying a TGF     RII-fl  oxed allele (  20  ). 
Langerin-Cre TGF     RII  f/f   mice are predicted to have LC 
precursors that are unable to respond to TGF     1. Langerin-
Cre TGF     RII  f/f   mice appeared grossly normal and had normal 
numbers of lymphocytes and DCs in their spleen and LN 
(unpublished data). In single-cell epidermal suspensions from 
these mice, there was a decreased number of MHC-II      cells 
compared with littermate Langerin-Cre TGF     II  f/f   controls 
(  Fig. 3 A  , top).   Although the number of LCs was substan-
tially reduced, a variable number of LCs were present in the 
epidermis of these mice. We hypothesized that residual LCs 
in Langerin-Cre TGF     RII  f/f   mice were cells that had not 
deleted both TGF     RII alleles. Indeed, all epidermal LCs 
pre  sent in Langerin-Cre TGF     RII  f/f   mice expressed TGF     RII 
at levels similar to littermate controls (  Fig. 3 A  , bottom). Thus, 
those LC precursors that continued to express TGF     RII, pre-
sumably because of failure to excise both fl  oxed loci, retained 
TGF      sensitivity and developed into LCs, whereas those in 
which both alleles of TGF     RII were excised did not. Thus, 
we conclude that LCs require the direct action of TGF     1 for 
their terminal development and/or survival. 
  Although the percentage of   “  escaped  ”   LCs present in the 
epidermis of Langerin-Cre TGF     RII  f/f   mice was always 
smaller than littermate controls, it was quite variable, ranging 
  Figure 2.     Langerin-Cre is selectively expressed in skin-derived LCs. (A) FACS analysis of CD11c-gated live cells obtained from the indicated tissues 
of littermate control (top) or Langerin-Cre Rosa26.EGFP (bottom) mice stained for DEC-205. (B) Analysis of CD11c-gated live cells from the indicated tis-
sue of Langerin-Cre mice stained for CD8      and Langerin.     2548 LANGERHANS CELLS REQUIRE AUTOCRINE TGF      | Kaplan et al.
the gene for TGF     1 was fl  oxed, thereby generating mice 
with a LC-selective ablation of TGF     1 (  24  ). These Lan-
gerin-Cre TGF     1  f/f   mice appeared grossly normal, did not 
have overt histologic evidence of autoimmune disease in the 
skin, and had normal numbers of lymphocytes and DCs in 
their spleen and LN (unpublished data). We consistently ob-
served a large decrease in the number of LCs in Langerin-Cre 
TGF     1  f/f   mice. LCs comprised 0.02  –  0.1% of epidermal cells 
in Langerin-Cre TGF     1  f/f   mice compared with 0.42  –  1.17% 
in littermate controls (  Fig. 4, A and B  ).   Immunofl  uorescence 
of whole-mounted ear epidermis confi  rmed this result. In 
Langerin-Cre TGF     1  f/f   mice, LCs were absent from the vast 
majority of the ear, but could be observed focally as MHC-II     , 
Langerin      cells in a few areas (  Fig. 4 C  ). As was seen with 
the Langerin-Cre TGF     RII  f/f   mice, escaped LCs were found 
in clusters that, interestingly, were often located at the edge 
of the ear. 
  TGF     1-fl  oxed mice were constructed by insertion of 
loxP sites 5      of the promoter region of   Tgfb1   and 3      of exon 1 
in the fi  rst intron (  24  ). The location of the loxP sites, how-
ever, encompasses the fi  nal exon of a hypothetical gene, 
  LOC232987  , leading to the abrogation of TGF     1 and 
LOC232987 expression. To address the possibility that the 
absence of LCs was caused by the absence of LOC232987 
and not TGF     1, Langerin-Cre TGF     1  f/n   mice were generated. 
TGF       n   mice have GFP inserted into the fi  rst exon of   Tgfb1   
gene that disrupts TGF     1 expression, but leaves LOC232987 
intact (  24  ). LCs in Langerin-Cre TGF     1  f/n   mice will have 
both alleles of the   Tgfb1   gene disrupted, but retain a func-
tional allele of LOC232987. These mice showed a dramatic 
decrease in the number of epidermal LCs and were indistin-
guishable from Langerin-Cre TGF     1  f/f   mice, thereby validat-
ing that the absence of LCs in Langerin-Cre TGF     1  f/f   mice 
was caused by the requirement for LC-derived TGF     1 (un-
published data). 
  The requirement for LC-derived TGF     1 in LC develop-
ment was unexpected, given the observation by Borkowski 
et al. that donor-derived LCs develop in TGF     1    −  /  −     →  WT BM 
chimeric mice ( 11  ). One explanation for the apparent discrep-
ancy between our results and theirs is that LC repopulation of 
the epidermis after BM transplantation may not be analogous 
to epidermal population during ontogeny and, in contrast to 
our results, could occur in the absence of LC-derived TGF    1. 
We examined this by creating BM chimeras using Langerin-
Cre TGF     1  f/f   and control littermate Cre    −    TGF     1  f/f   mice 
(both CD45.2     ) as BM donors and WT CD45.1 congenic 
B6 mice as recipients. Half of the recipients were treated with 
UVC 1 d after transplant, which eliminates host LCs and 
is known to enable the development of donor-derived LCs 
in the epidermis after BM transplantation (  22  ). Hematopoi-
etic engraftment in both sets of chimeras was confi  rmed by 
detecting CD45.2 by fl  ow cytometry 8 wk after transplant 
  Figure 3.     LC development requires the direct action of TGF    , and 
escaped LCs repopulate the epidermis in clusters. (A) FACS of live 
gated epidermal cells from Langerin-Cre TGF    RII f/f   (right) and littermate 
controls (left) stained for TGF     RII (top) or isotype control (bottom). (B) Each 
symbol represents the ratio of the percentage of epidermal LCs in an 
individual Langerin-Cre TGF    RII f/f   mouse compared with a sex- and age-
matched control. The percentage of LCs in Langerin-Cre TGF    RII f/f   in-
creases with age. P       0.05. (C) Immunofl  uorescence of epidermal whole 
mounts from Langerin-Cre TGF    RII f/f   at the indicated age or WT mice 
stained for MHC-II (green). The majority of fi  elds lack LCs. Representative 
fi  elds that contain LCs are shown. Bars: (Day 22) 37.5      m; (Days 60 and 
89 and WT) 75     m.   JEM VOL. 204, October 29, 2007  2549
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acts directly on LCs and not indirectly via another cell type. 
This was a nontrivial possibility given the large number of cell 
types that express receptors for TGF     . In addition, because 
Langerin, and hence Cre, are thought to be expressed only by 
mature LCs, our data indicates that LCs must require TGF     1 
after they begin to express Langerin (  14  ). Indeed, Langerin 
mRNA transcripts are detectable in the skin of TGF     1       /       
mice, and local introduction of TGF     1 can rescue LC develop-
ment in TGF     1       /       mice (  10, 25  ). Considering these results 
with our data, we conclude that LC precursors become TGF    1 
dependent only once they are in the skin and begin to express 
Langerin. TGF     1 signaling induces the transcription factor 
Id2 (  26  ). The absence of both LCs and splenic CD8      DCs 
in Id2       /       mice raised the possibility that both cell types may 
share a common TGF     1-dependent precursor (  26  ). The re-
quirement for TGF     1 by LCs only once they are already in 
the skin, however, suggests that Id2 could be required only 
after they have become distinct lineages. 
  Our observation that Langerin-Cre TGF     1  f/f   mice have 
a greatly reduced number of LCs clearly demonstrates a 
nonredundant, in vivo requirement for paracrine or autocrine 
TGF     1 for the development of mature LCs. Whether TGF     1 
acts transiently to foster LC development and/or is required as a 
survival factor is unclear. TGF     1 is produced by epidermal 
keratinocytes, making it plausible that LC-derived TGF    1 allows 
survival until LCs reach the epidermis, at which point keratino-
cytes could instead provide the necessary TGF     1. Hemato-
poietic stem cells (HSCs) were thought to use an autocrine/
paracrine TGF      loop to maintain HSC quiescence (  27  ). 
(unpublished data). As expected, immunofl  uorescence of 
epidermal whole mounts revealed that UVC-treated recipi-
ents of control Cre         TGF     1  f/f   BM developed normal num-
bers of CD45.2      (donor) Langerin      LCs throughout the 
epidermis (  Fig. 5 A  ).   In contrast, UVC-treated recipients of 
Langerin-Cre TGF     1  f/f   BM had virtually no detectable LCs, 
and the rare LCs present were of donor origin. Recipients 
of Langerin-Cre TGF     1  f/f   and control BM that were not 
irradiated with UVC retained LCs of recipient origin (  Fig. 5 B  ), 
as expected (  22  ). Thus, LC epidermal repopulation after 
BM transplantation recapitulated the steady state and, in our 
hands, is dependent on LC-derived TGF     1. 
  We have described the generation of Langerin-Cre, 
BAC-transgenic mice and demonstrated that expression of 
Cre in these mice is limited to epidermal and skin-derived 
LCs. By breeding these mice to fl  oxed TGF     RII and TGF     1 
mice, we developed mice in which LCs are either insensitive 
to or unable to produce TGF     1, respectively. The reduc-
tion of LCs in both of these strains of mice demonstrates that 
LC-derived TGF     1 directly and nonredundantly promotes 
LC development during ontogeny and in the steady state. 
Our BM transplantation experiments further demonstrate a 
requirement for LC-derived TGF     1, even during repopula-
tion after UV irradiation. 
  The general importance of TGF     1 in LC development 
was already appreciated based on the absence of LCs in 
TGF     1       /       mice and the ability of TGF     1 to enhance pro-
duction of LCs in in vitro cultures (  6  –  8  ). The lack of LCs 
in Langerin-Cre TGF     RII mice demonstrates that TGF     1 
  Figure 4.     Steady-state LC development requires LC-derived TGF     1. (A) A representative FACS analysis of live gated epidermal cells from 4-wk-old 
Langerin-Cre TGF    1 f/f   (right) compared with control mice (left). (B) Each symbol represents the percentage of LCs in an individual Langerin-Cre TGF     f/f  
mouse or control. (C) Immunofl  uorescence of epidermal whole mounts from Langerin-Cre TGF    1 f/f   or WT mice stained for MHC-II (green) and Langerin (red). 
As with the Langerin-Cre TGF    RII f/f ,  most  fi  elds lack LCs, and a representative fi  eld containing LCs is shown. Bar, 75     m.   2550 LANGERHANS CELLS REQUIRE AUTOCRINE TGF      | Kaplan et al.
what would otherwise be a very rare cell to expand. The obser-
vation that escaped LCs in Langerin-Cre TGF     RII  f/f   occur 
in clusters argues that fully diff  erentiated LCs derive from lo-
cally proliferating precursors in the steady state (  4, 21, 22  ). 
Moreover, the expanding size of the clusters with age sug-
gests that LCs are proliferating within the epidermis, though 
proliferation in the dermis and subsequent migration into the 
epidermis cannot be excluded. 
  Langerin-Cre TGF     1  →  WT UV-treated chimeras do not 
develop donor-derived LCs. Thus, LC-derived TGF     1 is 
required for LC repopulation after UV treatment, as well as 
to establish a normal complement of epidermal LCs during 
ontogeny. The absence of LCs in Langerin-Cre TGF       F/F  
chimeras was particularly surprising, given the presence of 
donor-derived LCs in the original TGF     1       /        →  WT ex-
periments by Borkowski et al. (  11  ). A potentially important 
distinction is that in the Borkowski et al. experiments, all 
hematopoietic cells lacked the gene for TGF     1, unlike Lan-
gerin-Cre TGF     1 chimeras, in which the defect was limited 
to LCs. Levels of TGF    2 are elevated in the skin of TGF1           /       
mice (  11  ). It is possible that in the absence of hematopoieti-
cally derived TGF     1, compensatory TGF     2 or other TGF      
family members such as activin, which potentially could pro-
mote LC development, were induced, and thus masked the 
physiologic requirement for LC-derived TGF     1 (  10, 11, 28  ). 
However, in vivo experiments, using conditionally ablated 
TGF     RII revealed that the absence of TGF      signaling had 
no eff  ect on HSCs, and the reliance on TGF      in vitro was 
presumably caused by an indirect eff  ect, such as the absence 
of soluble or environmental factors present in vivo (  27  ). This 
highlights the diffi   culty of studying TGF      in vitro and the 
importance of in vivo experimental systems. We believe this 
is the fi  rst documented hematopoietic cell type that is depen-
dent on TGF      for its development. Recent studies have also 
revealed an important function for T cell  –  derived TGF     1 in 
regulating T cell function (  24  ). Thus, regulation via TGF      
autocrine/paracrine loops may be a more common phenom-
enon than previously realized. 
  The deletion of the fl  oxed loci in TGF     RII  f/f   mice does 
not occur in every LC precursor, which allows some to retain 
sensitivity to TGF     1 and repopulate the empty epidermal 
niche. One explanation for this would be that rare LC pre-
cursors in Langerin-Cre mice express insuffi   cient levels of 
Cre to delete both alleles of the fl  oxed locus. This could ex-
plain why all LCs express EGFP in Langerin-Cre Rosa-EGFP 
mice, which only require deletion of a single fl  oxed allele. 
Other fl  oxed genes that are not required for LC survival, 
such as   I-A      , have both alleles effi   ciently excised by all LCs 
(unpublished data). Thus, it is more likely that the strong 
selective advantage of retaining sensitivity to TGF     1 allows 
  Figure 5.     LC repopulation in chimeric mice requires LC-derived TGF     1. BM chimeras were generated by transferring BM from either Langerin-
Cre      TGF   1 f/f   mice (A and B, bottom rows) or littermate Langerin-Cre   −    TGF   1 f/f   controls (A and B, top rows) into irradiated congenic B6.CD45.1 recipients. 
Recipients were either exposed to 450 mJ of UVC 1 d after transplant (A) or not irradiated (B). After 8 wk, immunofl  uorescence of epidermal ear whole 
mounts were stained for CD45.2 (green) and Langerin (red) to determine the presence of donor LCs. Representative data from three independent experi-
ments are shown. Bar, 75     m.   JEM VOL. 204, October 29, 2007  2551
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  Flow cytometry.     Single-cell suspensions of epidermis, LN, thymus, and 
spleen were obtained and stained as previously described (  12  ). Live/dead 
discrimination was obtained using propidium iodide (Invitrogen) or ethid-
ium monoazide (Invitrogen). Samples were analyzed on a FACSCalibur or 
LSR-II fl  ow cytometer (BD Biosciences). 
  Immunofl  uoresence.     Epidermal sheets were prepared by affi   xing ears to 
slides using double-sided adhesive (3M), followed by incubation in 21 mM 
EDTA in PBS for 2 h at 37  °   and physical removal of the dermis, as previ-
ously described (  12  ). 
  Generation of chimeric mice.     BM cells were obtained from either Lan-
gerin-Cre TGF       f/f   or Cre         littermate control mice. Cells were incubated in 
ACK buff  er for erythroid cell lysis and resuspended in injection buff  er (1       
PBS, 10 mM Hepes, 2.5% acid citrate dextrose anticoagulant, and 0.5% 
penicillin/streptomycin). Recipient B6 CD45.1 mice received 775 cGy from a 
cesium irradiator and were reconstituted with 10  7   cells/mouse. 1 d after trans-
plantation, one cohort of mice was exposed to 450 mJ UVC light. Mice were 
rested for at least 8 wk before experimentation. 
  Statistics.     Statistical comparisons between groups were made using a stan-
dard two-tailed Student  ’  s   t   test. Linear regression was used to evaluate for 
correlation in   Fig. 3 B  . 
  Online supplemental material.     Fig. S1 shows the generation of Lan-
gerin-Cre BAC. Fig. S2 shows that escaped epidermal MHC-II      cells in 
Langerin-Cre TGF     RII  f/f   mice are LCs. The online version of this article is 
available at http://www.jem.org/cgi/content/full/jem.20071401/DC1. 
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It is also important to note that Borkowski et al. observed 
donor-derived LCs in control and TGF     1       /       chimeras in 
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LCs are radio resistant, and repopulation from donor BM 
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the required initial autocrine/paracrine loop we have defi  ned 
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    MATERIALS AND METHODS   
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